Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
US6346398B1 · kind B1 · utility
92Cited by
6References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 1996 |
| Grant date | Feb 12, 2002 |
| Priority date | — |
| Expiry date | Jan 11, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/322
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nucleic acid molecule which modulates the synthesis, expression and/or stability of an mRNA encoding one or more receptors of vascular endothelial growth factor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.